By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Product revenue, net642K100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States642K100.00%
US Stock MarketDetailed Quotes
BioXcel Therapeutics (BTAI)
- 1.300
- +0.050+4.00%
Close May 6 16:00 ET
- 1.300
- 0.0000.00%
Post 20:01 ET
35.20MMarket Cap-0.23P/E (TTM)
1.370High1.240Low908.23KVolume1.240Open1.250Prev Close1.20MTurnover3.68%Turnover RatioLossP/E (Static)27.07MShares8.08052wk High-0.37P/B32.07MFloat Cap1.01052wk Low--Dividend TTM24.67MShs Float1144.000Historical High--Div Yield TTM10.40%Range %1.010Historical Low1.324Avg Price1Lot Size
BioXcel Therapeutics (BTAI) Revenue Breakdown Overview
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm